Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05530590 · ClinicalTrials.gov registry record · NA
Minnesota Inclusive LTSS for LGBTQ Seniors
A NA study of Alzheimer Disease and Dementia, sponsored by University of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 760
- Enrollment target
- 1
- Study location
NCT05530590: Active NA study of Alzheimer Disease and Dementia, sponsored by University of Minnesota.
NCT05530590 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 760 participants, below the 2,748-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05530590, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 760 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlled trial will rigorously test the effects of an in person versus an online training program on improving SGM culturally responsive care with a waitlist control.
Primary Outcome
Access to sexual and gender minority (SGM) providers, gender neutral intake forms
Conditions Studied
Interventions
- OTHER Training to Serve (TTS) in person training
- OTHER Training to Serve online training (eTTS)
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 760 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2026-07-04 |
| Phase | NA |
What the registry record for NCT05530590 still lists
NCT05530590 is an interventional study that assigns participants to a tested intervention. The registered 760 participants enrollment target is mid-sized for trials with a published cap, below the 2,748-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (72% lower).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Training to Serve (TTS) in person training is the first listed.
NCT05530590 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05530590 about?
NCT05530590 is a clinical study titled "Minnesota Inclusive LTSS for LGBTQ Seniors". This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlle...
What is the current status of trial NCT05530590?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 760 participants. The study started on 2024-01-31. Estimated completion is 2026-07-04.
What conditions does trial NCT05530590 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia.
What interventions are being tested in trial NCT05530590?
The interventions under investigation include: Training to Serve (TTS) in person training (OTHER), Training to Serve online training (eTTS) (OTHER).
Who is sponsoring clinical trial NCT05530590?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05530590 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05530590's enrollment target sits among peer trials
760 39th of 306 higher than 268 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05129228 · 760 participants · NA
Optical Coherence Tomography of the Saphenous Vein Graft
- NCT05787821 · 760 participants
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI